A team of scientists have bound gene editing CRISPR/Cas9 to nucleotide aptamers to selectively target and edit osteosarcoma cancer cells.
Browsing: Taxonomy > Pathology and cancer biology
Researchers have demonstrated that breast cancer can resurface 15 years after treatment, epigenetic editing has revealed a surprising insight into early breast cancer development and two breakthrough CDK4/6-inhibitor drugs have been approved for advanced breast cancer.
Researchers at the Ludwig Institute for Cancer Research (Brussels, Belgium) have discovered a novel mechanism used by tumors to evade immunotherapies.
A team of researchers have reported T cells survive a tumor’s anoxic environment and become more effective at killing cancer cells by exploiting HIF-1a and when they have access to growth factor VEGF-A.
Researchers have demonstrated for the first time, in mice, that carbon nanotubes may pose a similar carcinogenic effect as asbestos.
A recent study presented at The Liver Meeting® held by the American Association for the Study of Liver Diseases, demonstrates that daily aspirin therapy was significantly associated with a reduced risk in hepatitis B related liver cancer.
A novel study has demonstrated how the Warburg effect, a phenomenon in which cancer cells rapidly breaks down sugars, stimulates tumor growth
Researchers have discovered that lung cancer cells are able to utilize lactate as an energy source to facilitate growing. This finding challenges the previous understanding of cancer metabolism and may have implications for future cancer research.
A study has demonstrated the inhibitory effects of damsin – found in Ambrosia arborscens – on breast cancer stem cells. Ambrosin, a synthetically produced compound similar to damsin also has the same anti-cancer capabilities.
Recent research demonstrates that the ratio of abdominal fat to peripheral fat is a significant independent predictor of cancer.